Related Experiment Video

Updated: Aug 9, 2026

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

Population screening for colorectal cancer--how strong is the evidence?

Göran R Ekelund, Lars Janzon

    Acta Oncologica (Stockholm, Sweden)
    |March 21, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
    06:46

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

    Published on: September 27, 2024

    Related Experiment Videos

    Last Updated: Aug 9, 2026

    Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
    07:35

    Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

    Published on: June 8, 2020

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
    06:46

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

    Published on: September 27, 2024

    Related Concept Videos

    Serum Laboratory Studies, Stool Test, Breath Test01:30

    Serum Laboratory Studies, Stool Test, Breath Test

    Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
    Cancer Prevention02:59

    Cancer Prevention

    Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
    Some...

    Articles linked to this work by shared authors, journal, and citation graph.

    Incidence of ischemic stroke in relation to asymptomatic carotid artery atherosclerosis in subjects with normal blood pressure. A prospective cohort study.

    Cerebrovascular diseases (Basel, Switzerland)·2008

    Long-term stroke prognosis in relation to medical prevention and lifestyle factors. A prospective population-based study.

    Cerebrovascular diseases (Basel, Switzerland)·2008

    Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.

    Journal of medical screening·2007

    Social predictors of non-attendance in an urban mammographic screening programme: a multilevel analysis.

    Scandinavian journal of public health·2007

    Blood pressure in relation to the incidence of cerebral infarction and intracerebral hemorrhage. Hypertensive hemorrhage: debated nomenclature is still relevant.

    Stroke·2007

    Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.

    European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·2007

    Tolerability and adherence to adjuvant abemaciclib in hormone receptor-positive, HER2-negative, node-positive high-risk early breast cancer: a real-world study.

    Acta oncologica (Stockholm, Sweden)·2026

    Prognostic significance of isolated tumor cells and nodal tumor burden in endometrial cancer: a population-based cohort study.

    Acta oncologica (Stockholm, Sweden)·2026

    Improving cervical cancer screening uptake through theory-informed education: a comprehensive systematic review and meta-analysis.

    Acta oncologica (Stockholm, Sweden)·2026

    The Clinical outcomes following pencil beam scanning proton therapy for skull base chordoma and chondrosarcoma: a single-institution experience.

    Acta oncologica (Stockholm, Sweden)·2026

    User perceptions of machine learning models as decision support for colorectal cancer multidisciplinary team conferences (AID-SIM-2): a qualitative simulation study.

    Acta oncologica (Stockholm, Sweden)·2026

    Estimated number of children affected by paternal cancer diagnosis and death in Finland during 1970-2022: a population-based registry study.

    Acta oncologica (Stockholm, Sweden)·2026

    Systemic inflammatory indices primarily reflect tumor burden rather than independently predict prognosis in HPV-associated oropharyngeal squamous cell carcinoma.

    Acta oto-laryngologica·2026

    Genetically Predicted Gene Expression and Circulating Metabolites Associated with Cervical High-Grade Squamous Intraepithelial Lesion: A Mendelian Randomization Study.

    International journal of women's health·2026

    Cytological biomarkers and risk of malignancy in indeterminate thyroid nodules: a systematic review and meta-analysis.

    Endocrine oncology (Bristol, England)·2026

    Evaluation of CD10 expression in prostate adenocarcinoma and its clinic-pathological correlation at tertiary care hospital.

    Bioinformation·2026

    Endometriosis as a Silent Emerging Malignant Threat in Young Women: A Case Report of Rare Rapid Transformation of Abdominal Wall Endometriosis Into Mixed High-Grade Serous and Clear Cell Carcinoma One Year Following Cesarean Section.

    Cureus·2026

    Salivary cathelicidin LL-37 as a non-invasive biomarker for oral cancer detection.

    Bioinformation·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us